Drugs
-
Historical Information on Antidepressant Use in Children, Adolescents, and Adults
For current information on antidepressant use in children and adolescents, please see Antidepressant Use in Children, Adolescents, and Adults |
- December 13, 2006 meeting of the Psychopharmacologic Drugs Advisory Committee
- Public Health Advisory: Suicidality in Adults Being Treated with Antidepressant Medications (issued 6/30/2005)
- Antidepressant Drugs that have Healthcare Professional Sheets (6/30/2005)
- Labeling Template (PDF - 169KB) (2/3/2005)
- Medication Guide Template (PDF - 35KB) (2/3/2005)
- List of drugs receiving a boxed warning, other product labeling changes, and a Medication Guide pertaining to pediatric suicidality (PDF - 19KB) (2/3/2005)
- FDA releases questions and answers concerning the use of the antidepressant drug Effexor (venlafaxine) and the class of antidepressant drugs known as selective serotonin reuptake inhibitors, or SSRIs in adults. Effexor Information (12/7/2004)
- FDA Launches a Multi-Pronged Strategy to Strengthen Safeguards for Children Treated With Antidepressant Medications. FDA Press Release (issued 10/15/2004)
- Labeling Change Request Letter for Antidepressant Medications (issued 10/15/2004)
- FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committees (9/16/2004)
- September 13-14, 2004, Psychopharmacologic Drugs Advisory Committee, Joint Meeting with the Pediatric Advisory Committee. Meeting Information
- Public Health Advisory: Worsening Depression and Suicidality in Patients Being Treated with Antidepressant Medications (issued 3/22/2004)
- Background Information on the Suicidality Classification Project (issued 3/22/2004)
- Questions and Answers on Antidepressant Use in Children, Adolescents and Adults (issued 3/22/2004)
- February 2, 2004 meeting of the Psychopharmacologic Advisory Committee and the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee
- Pediatric Drug Development Web page
-
-